PARP-1 via regulation of p53 and p16, is involved in the hydroquinone-induced malignant transformation of TK6 cells by decelerating the cell cycle.

PARP-1 via regulation of p53 and p16, is involved in the hydroquinone-induced malignant transformation of TK6 cells by decelerating the cell cycle.
复制标题

PARP-1 通过调节 p53 和 p16,通过减慢细胞周期参与氢醌诱导的 TK6 细胞恶性转化。

DOI:
10.1016/j.tiv.2021.105153
复制
发表时间:
2021-03
影响因子:
3.2
通讯作者:
Hao Luo
Hao Luo
中科院分区:
医学3区
文献类型:
--
作者:
Lu Zhai;Hairong Liang;Jinlin Du;Mingwei Sun;Weifeng Qiu;Huanwen Tang;Hao Luo

文献摘要

参考文献

相似文献

聚腺苷二磷酸核糖聚合酶-1(PARP-1)在DNA损伤修复中起着重要作用,同时也是一种肿瘤促进基因和抑癌基因。然而,PARP-1在氢醌诱导的TK 6细胞恶性转化中的作用仍有待进一步阐明。本研究旨在探讨PARP-1在氢醌诱导TK 6细胞恶性转化中的作用机制。结果表明,高浓度的PARP-1抑制HQ慢性染毒后TK 6细胞的恶性转化。我们进一步证实,PARP-1过表达阻断细胞增殖,并在体外和体内减慢细胞周期进程。免疫印迹分析表明PARP-1通过p16/Rb和p53调控细胞周期进程。因此,我们得出结论,PARP-1参与HQ诱导的恶性转化与增加p16/Rb和p53,从而导致细胞周期进程减慢。
Poly(ADP-ribose)polymerase-1 (PARP-1) plays a crucial role in DNA damage repair and could be viewed as both a tumor promoter and tumor-suppressor gene. However, the effects of PARP-1 in hydroquinone-induced malignant transformation of TK6 cells remain to be further elucidated. The present research evaluated the potential mechanism of PARP-1 in hydroquinone-induced malignant transformation of TK6 cells. The results indicated that high PARP-1 inhibited TK6 cells malignant transformation after chronic exposure to HQ. We further confirmed that PARP-1 overexpression blocked cell proliferation, and decelerated cell cycle progression in vitro and in vivo. The immunoblotting analysis indicated that PARP-1 regulated cell cycle progression via p16/Rb and p53. Therefore, we conclude that PARP-1 is involved in HQ-induced malignant transformation associated with increasing p16/Rb and p53 which resulting in decelerating the cell cycle progression.
DOI: 10.1158/2159-8290.cd-12-0120
发表时间: 2012-12
期刊: Cancer discovery
影响因子: 28.2
作者:
Schiewer MJ;Goodwin JF;Han S;Brenner JC;Augello MA;Dean JL;Liu F;Planck JL;Ravindranathan P;Chinnaiyan AM;McCue P;Gomella LG;Raj GV;Dicker AP;Brody JR;Pascal JM;Centenera MM;Butler LM;Tilley WD;Feng FY;Knudsen KE
通讯作者: Knudsen KE
DOI: 10.22034/apjcp.2017.18.10.2845
发表时间: 2017-10-26
期刊: Asian Pacific journal of cancer prevention : APJCP
影响因子: --
作者:
Monger A;Boonmuen N;Suksen K;Saeeng R;Kasemsuk T;Piyachaturawat P;Saengsawang W;Chairoungdua A
通讯作者: Chairoungdua A
DOI: --
发表时间: 1999-05
期刊: Cancer research
影响因子: 11.2
作者:
C. Simbulan-Rosenthal;D. Rosenthal;Ruibai Luo;M. Smulson
通讯作者: C. Simbulan-Rosenthal;D. Rosenthal;Ruibai Luo;M. Smulson
DOI: 10.1093/emboj/16.19.6018
发表时间: 1997-10-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Vaziri, H;West, MD;Benchimol, S
通讯作者: Benchimol, S
DOI: 10.1371/journal.pone.0115558
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者:
Dziaman T;Ludwiczak H;Ciesla JM;Banaszkiewicz Z;Winczura A;Chmielarczyk M;Wisniewska E;Marszalek A;Tudek B;Olinski R
通讯作者: Olinski R